1Van Bree C, Beumer C, Ridermond H M, et al.Effectiveness of 2', 2'difluorodeoxy cytidine (Gemeitabine) combined with ehyperthermia in rat rlrhadomyisarcoma in vitro and in vivo[J]. Int J Hyperthermia, 1999,15(6) :549.
2Mohamed F,Marchettini P,Stuart O A,et al.Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia[J].Ann Surg Oncol,2003,10(4):463-468.
3Westermann A M,Grosen E A,Katschinski D M,et al.A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovavian cancer[J].Eur J Cancer,2001,37(9):1111-1117.
4Schiller J H,Harrington D,Belani C P,et al.Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer[J].N Engl J Med,2002,346(1):92-98.
5Huisman C,Smit E F,Gilaccone G,et al.Second-line chemotherapy in relapsing or refractory non-small-cell lung cancer:a review[J].J Clin Oncol,2000,18(21):3722-3730.
6Atanackovic D,Nierhaus A,Neumeier M,et al.41.8 degrees C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases[J].Cancer Immunol Immunother,2002,51(11-12):603-613.
